Extracellular sulfatases as potential blood-based biomarkers for early detection of lung cancer - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/33908819/

doi: 10.1080/01902148.2021.1885525. Online ahead of print. 1 Department of Surgery, Thoracic Oncology Program, University of California, San Francisco, San Francisco, California, USA. Purpose: Non-small lung (NSCLC) is the deadliest cancer, with survival measured in months. Earlier diagnosis using a robust biomarker would likely improve survival.